AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.
AutoPhagyGO's investors include UHA Mikakuto, Healthcare Innovation, Moresco, Makoto Naruke.
AutoPhagyGO is headquartered in Suita, Japan.
AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.
AutoPhagyGO is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AutoPhagyGO — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/autophagygo. Accessed August 13, 2026.
VCBacked. (2022). AutoPhagyGO — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/autophagygo
{{cite web |title=AutoPhagyGO — Funding & Investors |url=https://www.vcbacked.co/company/autophagygo |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated